87 related articles for article (PubMed ID: 3491887)
1. Fluorine-18-N-methylspiroperidol: radiolytic decomposition as a consequence of high specific activity and high dose levels.
MacGregor RR; Schlyer DJ; Fowler JS; Wolf AP; Shiue CY
J Nucl Med; 1987 Jan; 28(1):60-7. PubMed ID: 3491887
[TBL] [Abstract][Full Text] [Related]
2. No-carrier-added fluorine-18-labeled N-methylspiroperidol: synthesis and biodistribution in mice.
Shiue CY; Fowler JS; Wolf AP; McPherson DW; Arnett CD; Zecca L
J Nucl Med; 1986 Feb; 27(2):226-34. PubMed ID: 3712039
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective synthesis of 6-[fluorine-18]-fluoro-L-dopa from no-carrier-added fluorine-18-fluoride.
Lemaire C; Damhaut P; Plenevaux A; Comar D
J Nucl Med; 1994 Dec; 35(12):1996-2002. PubMed ID: 7989984
[TBL] [Abstract][Full Text] [Related]
4. Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone.
Shiue CY; Fowler JS; Wolf AP; Watanabe M; Arnett CD
J Nucl Med; 1985 Feb; 26(2):181-6. PubMed ID: 2857191
[TBL] [Abstract][Full Text] [Related]
5. Aromatic radiofluorination with [18F]fluorine gas: 6-[18F]fluoro-L-dopa.
Firnau G; Chirakal R; Garnett ES
J Nucl Med; 1984 Nov; 25(11):1228-33. PubMed ID: 6436449
[TBL] [Abstract][Full Text] [Related]
6. High yield synthesis of 6-[18F]fluoro-L-dopa by regioselective fluorination of protected L-dopa with [18F]acetylhypofluorite.
Chaly T; Diksic M
J Nucl Med; 1986 Dec; 27(12):1896-901. PubMed ID: 3097278
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 labeling of proteins.
Kilbourn MR; Dence CS; Welch MJ; Mathias CJ
J Nucl Med; 1987 Apr; 28(4):462-70. PubMed ID: 3494825
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of fluorine-18 21-fluoroprednisone as a potential ligand for neuro-PET studies.
Feliu AL; Rottenberg DA
J Nucl Med; 1987 Jun; 28(6):998-1005. PubMed ID: 3495649
[TBL] [Abstract][Full Text] [Related]
9. Electron impact mass spectrometry of substituted 1,3,8-triazaspiro[4,5]decan-4-ones.
Danieli B; Rubino FM; Zecca L
Biomed Environ Mass Spectrom; 1989 Nov; 18(11):1000-4. PubMed ID: 2620151
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET).
Dewey SL; Logan J; Wolf AP; Brodie JD; Angrist B; Fowler JS; Volkow ND
Synapse; 1991 Apr; 7(4):324-7. PubMed ID: 2042113
[No Abstract] [Full Text] [Related]
11. One-step high-radiochemical-yield synthesis of [18F]FP-CIT using a protic solvent system.
Lee SJ; Oh SJ; Chi DY; Kang SH; Kil HS; Kim JS; Moon DH
Nucl Med Biol; 2007 May; 34(4):345-51. PubMed ID: 17499723
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of a new [18F]fluoropyridine-based haloacetamide reagent for the labeling of oligonucleotides: 2-bromo-N-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]acetamide.
Kuhnast B; de Bruin B; Hinnen F; Tavitian B; Dollé F
Bioconjug Chem; 2004; 15(3):617-27. PubMed ID: 15149190
[TBL] [Abstract][Full Text] [Related]
13. [18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain.
Arnett CD; Fowler JS; Wolf AP; Shiue CY; McPherson DW
Life Sci; 1985 Apr; 36(14):1359-66. PubMed ID: 3872397
[TBL] [Abstract][Full Text] [Related]
14. Microscale synthesis of nitrogen-13-labeled cisplatin.
De Spiegeleer B; Slegers G; Vandecasteele C; Van den Bossche W; Schelstraete K; Claeys A; De Moerloose P
J Nucl Med; 1986 Mar; 27(3):399-403. PubMed ID: 3712059
[TBL] [Abstract][Full Text] [Related]
15. Radiolysis of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) and the role of ethanol and radioactive concentration.
Jacobson MS; Dankwart HR; Mahoney DW
Appl Radiat Isot; 2009 Jun; 67(6):990-5. PubMed ID: 19231219
[TBL] [Abstract][Full Text] [Related]
16. A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET.
Fowler JS; Arnett CD; Wolf AP; Shiue CY; MacGregor RR; Halldin C; Långström B; Wagner HN
Int J Rad Appl Instrum B; 1986; 13(3):281-4. PubMed ID: 3771261
[TBL] [Abstract][Full Text] [Related]
17. No-carrier-added N-(3-[18F]fluoropropyl)spiroperidol: biodistribution in mice and tomographic studies in a baboon.
Shiue CY; Bai LQ; Teng RR; Arnett CD; Wolf AP
J Nucl Med; 1987 Jul; 28(7):1164-70. PubMed ID: 3496434
[TBL] [Abstract][Full Text] [Related]
18. Automated synthesis of n.c.a. [18F]FDOPA via nucleophilic aromatic substitution with [18F]fluoride.
Shen B; Ehrlichmann W; Uebele M; Machulla HJ; Reischl G
Appl Radiat Isot; 2009 Sep; 67(9):1650-3. PubMed ID: 19433364
[TBL] [Abstract][Full Text] [Related]
19. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.
Arnett CD; Wolf AP; Shiue CY; Fowler JS; MacGregor RR; Christman DR; Smith MR
J Nucl Med; 1986 Dec; 27(12):1878-82. PubMed ID: 3491193
[TBL] [Abstract][Full Text] [Related]
20. Routine synthesis of L-[18F]6-fluorodopa with fluorine-18 acetyl hypofluorite.
Adam MJ; Ruth TJ; Grierson JR; Abeysekera B; Pate BD
J Nucl Med; 1986 Sep; 27(9):1462-6. PubMed ID: 3091786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
